Literature DB >> 15660519

The silent revolution: RNA interference as basic biology, research tool, and therapeutic.

Derek M Dykxhoorn1, Judy Lieberman.   

Abstract

RNA interference (RNAi) is an evolutionarily conserved mechanism for silencing gene expression. In primitive organisms, RNAi protects the genome from viruses and other insertable genetic elements and regulates gene expression during development. The antisense (guide) strand of short double-stranded RNAs is incorporated into an RNA-induced silencing complex that can either suppress protein expression or direct degradation of messenger RNAs that contain homologous sequence(s). The discovery that RNAi works in mammalian cells has sparked intense investigation into its role in normal mammalian cell function, its use as a tool to understand or screen for genes functioning in cellular pathways in healthy and diseased cells and animals, and its potential for therapeutic gene silencing. RNAi may provide an important new therapeutic modality for treating infection, cancer, neurodegenerative disease, and other illnesses, although in vivo delivery of small interfering RNAs into cells remains a significant obstacle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660519     DOI: 10.1146/annurev.med.56.082103.104606

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  84 in total

1.  C. elegans RNAi space experiment (CERISE) in Japanese Experiment Module KIBO.

Authors:  Atsushi Higashitani; Toko Hashizume; Tomoko Sugimoto; Chihiro Mori; Kanako Nemoto; Timothy Etheridge; Nahoko Higashitani; Takako Takanami; Hiromi Suzuki; Keiji Fukui; Takashi Yamazaki; Noriaki Ishioka; Nathaniel Szewczyk; Akira Higashibata
Journal:  Biol Sci Space       Date:  2009-10-01

Review 2.  Ligand-targeted delivery of therapeutic siRNA.

Authors:  Yutaka Ikeda; Kazunari Taira
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism.

Authors:  Derek M Dykxhoorn; Lisa D Schlehuber; Irving M London; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

4.  Breakthrough in silencing "bad" genes.

Authors:  Anthony L Komaroff
Journal:  MedGenMed       Date:  2006-03-31

5.  Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

Authors:  Rosario Sabariegos; Mireia Giménez-Barcons; Natalia Tàpia; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 6.  Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Authors:  Dirk Grimm; Mark A Kay
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27

8.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 9.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

10.  Cationic Hyperbranched Polymers with Biocompatible Shells for siRNA Delivery.

Authors:  Sipei Li; Maiko Omi; Francis Cartieri; Dominik Konkolewicz; Gordon Mao; Haifeng Gao; Saadyah E Averick; Yuji Mishina; Krzysztof Matyjaszewski
Journal:  Biomacromolecules       Date:  2018-08-27       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.